tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

IONS Stock Latest News

Cathie Wood Doubles Down on High-Potential Biotech Plays
Market NewsCathie Wood Doubles Down on High-Potential Biotech Plays
2d ago
TER
TXG
RBLX, META, GH, IONS: Cathie Wood Loads Up on Roblox, Trims Meta and Biotech Stocks
PremiumMarket News
RBLX, META, GH, IONS: Cathie Wood Loads Up on Roblox, Trims Meta and Biotech Stocks
9d ago
GH
KDK
Ionis Pharmaceuticals: Underappreciated Bepirovirsen and Multiple Late-Stage Catalysts Support Buy Rating
PremiumRatings
Ionis Pharmaceuticals: Underappreciated Bepirovirsen and Multiple Late-Stage Catalysts Support Buy Rating
9d ago
IONS
Ionis Advances Bepirovirsen After Positive Phase 3 Results
PremiumCompany Announcements
Ionis Advances Bepirovirsen After Positive Phase 3 Results
9d ago
8K
IONS
Ionis partner GSK reports B-Well 1, B-Well 2 studies met primary endpoint
PremiumThe Fly
Ionis partner GSK reports B-Well 1, B-Well 2 studies met primary endpoint
9d ago
GSK
IONS
Ionis Pharmaceuticals price target raised to $100 from $82 at Wells Fargo
PremiumThe FlyIonis Pharmaceuticals price target raised to $100 from $82 at Wells Fargo
11d ago
IONS
Cathie Wood Wraps Up 2025 with New Biotech Buys — Here’s What It Sold
Premium
Market News
Cathie Wood Wraps Up 2025 with New Biotech Buys — Here’s What It Sold
15d ago
BEAM
Cathie Wood Closes Out 2025 with a Rocket Lab (RKLB) Trim and Fresh Biotech Bets
Premium
Market News
Cathie Wood Closes Out 2025 with a Rocket Lab (RKLB) Trim and Fresh Biotech Bets
16d ago
BEAM
IONS
IONS, IBTA, IRDM: Cathie Wood Continues Trimming Stakes in Ionis, Ibotta, and Iridium Stocks
PremiumMarket News
IONS, IBTA, IRDM: Cathie Wood Continues Trimming Stakes in Ionis, Ibotta, and Iridium Stocks
25d ago
IBTA
IONS
Ionis Pharmaceuticals price target raised to $95 from $82 at RBC Capital
PremiumThe Fly
Ionis Pharmaceuticals price target raised to $95 from $82 at RBC Capital
30d ago
IONS
Arrowhead price target raised to $100 from $70 at Piper Sandler
PremiumThe Fly
Arrowhead price target raised to $100 from $70 at Piper Sandler
30d ago
ARWR
IONS
Ionis Pharmaceuticals price target raised to $100 from $85 at Leerink
PremiumThe Fly
Ionis Pharmaceuticals price target raised to $100 from $85 at Leerink
1M ago
ALNY
BBIO
Ionis Pharmaceuticals price target raised to $97 from $86 at BofA
PremiumThe FlyIonis Pharmaceuticals price target raised to $97 from $86 at BofA
1M ago
IONS
Ionis Pharmaceuticals: Promising Growth Driven by Key Product Launches and Strategic Partnerships
Premium
Ratings
Ionis Pharmaceuticals: Promising Growth Driven by Key Product Launches and Strategic Partnerships
1M ago
IONS
Ionis Pharmaceuticals gets Breakthrough Therapy designation for zilganersen
Premium
The Fly
Ionis Pharmaceuticals gets Breakthrough Therapy designation for zilganersen
1M ago
IONS
Ionis Pharmaceuticals granted Breakthrough Therapy designation for olezarsen
PremiumThe Fly
Ionis Pharmaceuticals granted Breakthrough Therapy designation for olezarsen
2M ago
IONS
Arrowhead price target raised to $48 from $27 at Goldman Sachs
PremiumThe Fly
Arrowhead price target raised to $48 from $27 at Goldman Sachs
2M ago
ARWR
IONS
Ionis Pharmaceuticals Completes $770M Convertible Notes Offering
PremiumCompany Announcements
Ionis Pharmaceuticals Completes $770M Convertible Notes Offering
2M ago
8K
IONS
Ionis Pharmaceuticals announces CHMP opinion recommending Dawnzera approval
PremiumThe Fly
Ionis Pharmaceuticals announces CHMP opinion recommending Dawnzera approval
2M ago
IONS
Arrowhead price target raised to $45 from $29 at Morgan Stanley
PremiumThe FlyArrowhead price target raised to $45 from $29 at Morgan Stanley
2M ago
ARWR
IONS
Ionis Pharmaceuticals announces $700M convertible senior notes offering
Premium
The Fly
Ionis Pharmaceuticals announces $700M convertible senior notes offering
2M ago
IONS
Ionis Pharmaceuticals’ Olezarsen: Promising Phase 3 Results and Blockbuster Potential Justify Buy Rating
Premium
Ratings
Ionis Pharmaceuticals’ Olezarsen: Promising Phase 3 Results and Blockbuster Potential Justify Buy Rating
2M ago
IONS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >